These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 5561774)

  • 1. [Suggestions and recommendations for standardization of the systemic "routine" control during the production of the pharmaceutical dosage forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Mar; 110(3):131-46 contd. PubMed ID: 5561774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suggestions and recommendations for standardization of the systemic routine control during production of pharmaceutical forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Feb; 110(2):70-82. PubMed ID: 5561771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Suggestions and recommendations for standardization of the systemic "routine" controls during the production of pharmaceutical forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Jun; 110(6):298-311 contd. PubMed ID: 5110577
    [No Abstract]   [Full Text] [Related]  

  • 4. [Suggestions and recommendations for standardization of the systematic routine controls during the production of pharmaceutical dosage forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Jul; 110(7):353-67 contd. PubMed ID: 5125635
    [No Abstract]   [Full Text] [Related]  

  • 5. [Suggestions and recommendations for standardization of systemic "routine" controls during production of pharmaceutical forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 May; 110(5):266-77. PubMed ID: 5111682
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Suggestions and recommendations for the standardization of systematic "routine" controls during the production of pharmaceutical forms and their manufacture].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Oct; 110(10):584-9. PubMed ID: 5143358
    [No Abstract]   [Full Text] [Related]  

  • 8. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 9. [Uniformity of unit-dose pharmaceutical preparations. Tests for the specifications of the uniformity of the pharmacopoeias, evaluation of the permitted variability, transfer of specifications to the control of production, variability found in the Italian pharmaceutical production, proposals for future specifications of uniformity].
    Cavatorta L; Cingolani E; Fontani F; Mecarelli E; Melandri MM; Pietra E; Pietra V; Rocchi B
    Boll Chim Farm; 1973 Apr; 112(4):226-45. PubMed ID: 4721646
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report.
    World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in pharmaceutical technology in years 1966-1967. I. General works, pharmaceutic aids, manufacturing processes, packing technic].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Oct; 17(8):392-8. PubMed ID: 4888355
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticipated revisions to the current good manufacturing practice regulations.
    Mitchell CM
    Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of RFID tag readability for pharmaceutical products at item level.
    Erdem E; Zeng H; Zhou J; Shi J; Wells DL
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1312-24. PubMed ID: 19832631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmaceutical advice concerning different pharmaceutical dosage forms].
    Szakonyi G; Zelkó R
    Acta Pharm Hung; 2010; 80(3):121-7. PubMed ID: 21222322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing.
    Burcham CL; Florence AJ; Johnson MD
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():253-281. PubMed ID: 29879381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations].
    Antal I
    Acta Pharm Hung; 2006; 76(3):149-54. PubMed ID: 17094663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development in drug control].
    Marini Bettolo GB
    Farmaco Prat; 1971 Jul; 26(7):367-82. PubMed ID: 5561802
    [No Abstract]   [Full Text] [Related]  

  • 20. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.